Stages in Discovery: Angiotensin-Converting Enzyme Type 2 and Stroke.
From the Universidad de los Andes, School of Medicine, Bogota, Colombia (R.A.P.-S.); and Departments of Neurosurgery (R.A.P.-S.) and Internal Medicine and Pharmacology (D.D.H.), University of Iowa, Carver College of Medicine, Iowa City.
Ricardo A
RA
Peña-Silva
From the Universidad de los Andes, School of Medicine, Bogota, Colombia (R.A.P.-S.); and Departments of Neurosurgery (R.A.P.-S.) and Internal Medicine and Pharmacology (D.D.H.), University of Iowa, Carver College of Medicine, Iowa City. donald-heistad@uiowa.edu.
Donald D
DD
Heistad
D000818:Animals; D002540:Cerebral Cortex / Q000201:enzymology*; D003342:Corpus Striatum / Q000201:enzymology*; D004133:Diminazene / Q000031:analogs & derivatives*; D020244:Infarction, Middle Cerebral Artery / Q000201:enzymology*; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D007703:Peptidyl-Dipeptidase A / Q000502:physiology*
D018696:Neuroprotective Agents; D007703:Peptidyl-Dipeptidase A; D004133:Diminazene